Asep Financial Statements From 2010 to 2026
| SEPSF Stock | USD 0.01 0.00 0.00% |
Check Asep Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Asep Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Asep financial statements analysis is a perfect complement when working with Asep Medical Valuation or Volatility modules.
Asep |
Asep Medical Holdings Company Current Valuation Analysis
Asep Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Asep Medical Current Valuation | 16.86 M |
Most of Asep Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asep Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Asep Medical Holdings has a Current Valuation of 16.86 M. This is 99.88% lower than that of the Healthcare sector and 99.64% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.9% higher than that of the company.
Asep Medical Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Asep Medical's current stock value. Our valuation model uses many indicators to compare Asep Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asep Medical competition to find correlations between indicators driving Asep Medical's intrinsic value. More Info.Asep Medical Holdings is currently regarded number one company in current valuation category among its peers. It is rated second in shares outstanding category among its peers creating about 3.69 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Asep Medical's earnings, one of the primary drivers of an investment's value.About Asep Medical Financial Statements
Asep Medical stakeholders use historical fundamental indicators, such as Asep Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Asep Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Asep Medical's assets and liabilities are reflected in the revenues and expenses on Asep Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Asep Medical Holdings. Please read more on our technical analysis and fundamental analysis pages.
Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications. Asep Medical Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada. Asep Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Asep Pink Sheet
Asep Medical financial ratios help investors to determine whether Asep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asep with respect to the benefits of owning Asep Medical security.